Uncovering the Genetic Cause of Familial Diabetes: How Precision Diagnosis Can Change the Course of Care

‍

Three generations of the same family developed diabetes at a young age. Yet despite years of treatment, the cause remained unclear.

Tim (pseudonym) was still a teenager when he was diagnosed with diabetes. His mother had developed diabetes in her 30s, and his grandmother in her 20s. Across three generations, the family seemed to share a pattern that could not be explained by chance alone.

To manage his condition, Tim had to endure daily insulin injections. But even with ongoing treatment, his blood sugar remained difficult to control. For Tim and his family, the uncertainty was as difficult as the disease itself: Why was this happening, and why did standard treatment not seem to work as expected?

‍

When the diagnosis does not fully explain the disease

Cases like Tim’s illustrate a challenge that many families with hereditary conditions face: a long and frustrating diagnostic odyssey. Patients may see multiple physicians, undergo repeated testing, and still not receive an answer that fully explains their condition.

In some cases, the underlying cause may not fit neatly into common disease categories such as type 1 or type 2 diabetes. When that happens, treatment decisions based on an incomplete diagnosis may not deliver the intended clinical benefit.

Traditional genetic testing approaches can be valuable, but they also have limitations. Depending on the method used, some tests focus only on selected genes or specific regions of the genome. If the disease-causing variant lies outside those regions, the result may remain inconclusive.

‍

Looking beyond conventional testing with whole genome sequencing

This is where ACTInherit Whole Genome Sequencing (WGS) may offer important additional insight.

ACTInherit is designed to analyze the genome more comprehensively in a single workflow, examining approximately 3 billion DNA base pairs across the entire genome. By moving beyond selected targets and expanding the scope of analysis, WGS may help identify pathogenic variants that conventional approaches can miss.

For families with complex or unresolved presentations, this broader genomic view can provide a more complete foundation for clinical evaluation.

‍

A turning point: identifying the underlying genetic cause

Through ACTInherit, Tim’s family was found to have a hereditary form of diabetes known as Maturity-Onset Diabetes of the Young (MODY).

This result changed the clinical understanding of the case. Rather than type 1 or type 2 diabetes, the condition had a distinct genetic basis that required a different management approach.

A more precise molecular diagnosis gave the care team new direction and supported a reassessment of treatment strategy.

‍

Why precision diagnosis matters

Once the diagnosis of MODY was established, Tim’s medical team adjusted his treatment plan accordingly. Instead of relying on the previous approach alone, they introduced an oral medication strategy appropriate to the subtype identified. Following this adjustment, his glycemic control improved significantly over time.

For patients and families, this kind of diagnostic clarification can have important implications. A more accurate diagnosis may help:

• Guide more appropriate treatment decisions

• Reduce unnecessary or ineffective interventions

• Support prognosis and long-term care planning

• Inform family counseling and risk assessment across generations

In hereditary disease care, diagnosis is not simply a label. It is often the starting point for more informed and individualized management.

‍

The value of finding the right answer earlier

Behind some complex or difficult-to-control conditions, there may be an underlying genetic explanation that has not yet been identified.

For families who have experienced years of uncertainty, repeated testing, or inconclusive results, comprehensive genomic analysis may provide an opportunity to uncover information that changes the direction of care. ACTInherit is not just an additional test option. In selected cases, it may serve as a more comprehensive diagnostic tool for uncovering the genetic basis of disease.

At ACT Genomics, we believe that clearer genomic insight can help clinicians and families move forward with greater confidence, direction, and understanding. If you or a family member has experienced a long diagnostic journey, undergone multiple inconclusive genetic tests, or is suspected of having a hereditary condition, it may be worth discussing whether broader genomic analysis is appropriate.

To learn more about ACTInherit, please contact ACT Genomics’ Genetic Counseling team: service@actgenomics.com.

Disclaimer

This content is provided for informational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Any testing or treatment decisions should be made by qualified healthcare professionals based on each patient’s individual condition and the latest clinical evidence.

‍